Skip to main content
SpringerLink
Log in

Malignant Pediatric Liver Tumors

  • Chapter
Surgical Pathology of Liver Tumors

  • 1952 Accesses

Abstract

Several malignant neoplasms occur almost exclusively in the infant and pediatric liver. Hepatoblastomas are discussed and illustrated, including the different subtypes and prognostic features. The recently described calcifying nested-stromal epithelial tumor is illustrated, along with the differential. Most of these tumors have indolent behavior, but some can be aggressive. Other malignancies are described and illustrated, including germ cell tumors and the mesenchymal malignances of embryonal sarcoma and embryonal rhabdomyosarcoma. Finally, pediatric hepatocellular carcinomas and cholangiocarcinomas are reviewed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Giardiello FM, Petersen GM, Brensinger JD, Luce MC, Cayouette MC, Bacon J, et al. Hepatoblastoma and APC gene mutation in familial adenomatous polyposis. Gut. 1996;39:867–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  2. DeBaun MR, Tucker MA. Risk of cancer during the first four years of life in children from The Beckwith-Wiedemann Syndrome Registry. J Pediatr. 1998;132:398–400.

    Article  CAS  PubMed  Google Scholar 

  3. Maruyama K, Ikeda H, Koizumi T. Hepatoblastoma associated with trisomy 18 syndrome: a case report and a review of the literature. Pediatr Int. 2001;43:302–5.

    Article  CAS  PubMed  Google Scholar 

  4. Kamien BA, Gabbett MT. Aicardi syndrome associated with hepatoblastoma and pulmonary sequestration. Am J Med Genet A. 2009;149A:1850–2.

    Article  PubMed  Google Scholar 

  5. Eren E, Demirkaya M, Cakir ED, Sevinir B, Saglam H, Tarim O. A rare cause of precocious puberty: hepatoblastoma. J Clin Res Pediatr Endocrinol. 2009;1:281–3.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Unal E, Koksal Y, Akcoren Z, Tavl L, Gunel E, Kerimoglu U. Mesenchymal hamartoma of the liver mimicking hepatoblastoma. J Pediatr Hematol Oncol. 2008;30:458–60.

    Article  PubMed  Google Scholar 

  7. Cajaiba MM, Sarita-Reyes C, Zambrano E, Reyes-Mugica M. Mesenchymal hamartoma of the liver associated with features of Beckwith-Wiedemann syndrome and high serum alpha-fetoprotein levels. Pediatr Dev Pathol. 2007;10:233–8.

    Article  CAS  PubMed  Google Scholar 

  8. Boman F, Bossard C, Fabre M, Diab N, Bonnevalle M, Boccon-Gibod L. Mesenchymal hamartomas of the liver may be associated with increased serum alpha foetoprotein concentrations and mimic hepatoblastomas. Eur J Pediatr Surg. 2004;14:63–6.

    Article  CAS  PubMed  Google Scholar 

  9. Han SJ, Tsai CC, Tsai HM, Chen YJ. Infantile hemangioendothelioma with a highly elevated serum alpha-fetoprotein level. Hepatogastroenterology. 1998;45:459–61.

    CAS  PubMed  Google Scholar 

  10. Sari N, Yalcin B, Akyuz C, Haliloglu M, Buyukpamukcu M. Infantile hepatic hemangioendothelioma with elevated serum alpha-fetoprotein. Pediatr Hematol Oncol. 2006;23:639–47.

    Article  PubMed  Google Scholar 

  11. De Ioris M, Brugieres L, Zimmermann A, Keeling J, Brock P, Maibach R, et al. Hepatoblastoma with a low serum alpha-fetoprotein level at diagnosis: the SIOPEL group experience. Eur J Cancer. 2008;44:545–50.

    Article  PubMed  Google Scholar 

  12. Feusner JH, Krailo MD, Haas JE, Campbell JR, Lloyd DA, Ablin AR. Treatment of pulmonary metastases of initial stage I hepatoblastoma in childhood. Report from the Childrens Cancer Group. Cancer. 1993;71:859–64.

    Article  CAS  PubMed  Google Scholar 

  13. Fuchs J, Rydzynski J, Von Schweinitz D, Bode U, Hecker H, Weinel P, et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer. 2002;95:172–82.

    Article  PubMed  Google Scholar 

  14. Maibach R, Roebuck D, Brugieres L, Capra M, Brock P, Dall’Igna P, et al. Prognostic stratification for children with hepatoblastoma: the SIOPEL experience. Eur J Cancer. 2012;48:1543–9.

    Article  PubMed  Google Scholar 

  15. Meyers RL, Rowland JR, Krailo M, Chen Z, Katzenstein HM, Malogolowkin MH. Predictive power of pretreatment prognostic factors in children with hepatoblastoma: a report from the Children’s Oncology Group. Pediatr Blood Cancer. 2009;53:1016–22.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Lopez-Terrada D, Alaggio R, de Davila MT, Czauderna P, Hiyama E, Katzenstein H, et al. Towards an international pediatric liver tumor consensus classification: proceedings of the Los Angeles COG liver tumors symposium. Mod Pathol. 2014;27:472–91.

    Article  PubMed  Google Scholar 

  17. Schmidt A, Braeuning A, Ruck P, Seitz G, Armeanu-Ebinger S, Fuchs J, et al. Differential expression of glutamine synthetase and cytochrome P450 isoforms in human hepatoblastoma. Toxicology. 2011;281:7–14.

    Article  CAS  PubMed  Google Scholar 

  18. Tomlinson GE, Douglass EC, Pollock BH, Finegold MJ, Schneider NR. Cytogenetic evaluation of a large series of hepatoblastomas: numerical abnormalities with recurring aberrations involving 1q12-q21. Genes Chromosomes Cancer. 2005;44:177–84.

    Article  CAS  PubMed  Google Scholar 

  19. Lopez-Terrada D, Gunaratne PH, Adesina AM, Pulliam J, Hoang DM, Nguyen Y, et al. Histologic subtypes of hepatoblastoma are characterized by differential canonical Wnt and Notch pathway activation in DLK+ precursors. Hum Pathol. 2009;40:783–94.

    Article  CAS  PubMed  Google Scholar 

  20. Adesina AM, Lopez-Terrada D, Wong KK, Gunaratne P, Nguyen Y, Pulliam J, et al. Gene expression profiling reveals signatures characterizing histologic subtypes of hepatoblastoma and global deregulation in cell growth and survival pathways. Hum Pathol. 2009;40:843–53.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Tan X, Apte U, Micsenyi A, Kotsagrelos E, Luo JH, Ranganathan S, et al. Epidermal growth factor receptor: a novel target of the Wnt/beta-catenin pathway in liver. Gastroenterology. 2005;129:285–302.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  22. Jamieson C, Sharma M, Henderson BR. Wnt signaling from membrane to nucleus: beta-catenin caught in a loop. Int J Biochem Cell Biol. 2012;44:847–50.

    Article  CAS  PubMed  Google Scholar 

  23. Park WS, Oh RR, Park JY, Kim PJ, Shin MS, Lee JH, et al. Nuclear localization of beta-catenin is an important prognostic factor in hepatoblastoma. J Pathol. 2001;193:483–90.

    Article  CAS  PubMed  Google Scholar 

  24. Oue T, Yoneda A, Uehara S, Yamanaka H, Fukuzawa M. Increased expression of the hedgehog signaling pathway in pediatric solid malignancies. J Pediatr Surg. 2010;45:387–92.

    Article  PubMed  Google Scholar 

  25. Trobaugh-Lotrario AD, Finegold MJ, Feusner JH. Rhabdoid tumors of the liver: rare, aggressive, and poorly responsive to standard cytotoxic chemotherapy. Pediatr Blood Cancer. 2011;57:423–8.

    Article  PubMed  Google Scholar 

  26. Kachanov D, Teleshova M, Kim E, Dobrenkov K, Moiseenko R, Usychkina A, et al. Malignant rhabdoid tumor of the liver presented with initial tumor rupture. Cancer Genet. 2014;207:412–4.

    Article  PubMed  Google Scholar 

  27. Clairotte A, Ringenbach F, Laithier V, Aubert D, Kantelip B. [Malignant rhabdoid tumor of the liver with spontaneous rupture: a case report]. Ann Pathol. 2006;26:122–5.

    Article  PubMed  Google Scholar 

  28. Ravindra KV, Cullinane C, Lewis IJ, Squire BR, Stringer MD. Long-term survival after spontaneous rupture of a malignant rhabdoid tumor of the liver. J Pediatr Surg. 2002;37:1488–90.

    Article  CAS  PubMed  Google Scholar 

  29. Yuri T, Danbara N, Shikata N, Fujimoto S, Nakano T, Sakaida N, et al. Malignant rhabdoid tumor of the liver: case report and literature review. Pathol Int. 2004;54:623–9.

    Article  PubMed  Google Scholar 

  30. Scheimberg I, Cullinane C, Kelsey A, Malone M. Primary hepatic malignant tumor with rhabdoid features. A histological, immunocytochemical, and electron microscopic study of four cases and a review of the literature. Am J Surg Pathol. 1996;20:1394–400.

    Article  CAS  PubMed  Google Scholar 

  31. Eaton KW, Tooke LS, Wainwright LM, Judkins AR, Biegel JA. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer. 2011;56:7–15.

    Article  PubMed Central  PubMed  Google Scholar 

  32. Donner LR, Rao A, Truss LM, Dobin SM. Translocation (8;13)(q24.2;q33) in a malignant rhabdoid tumor of the liver. Cancer Genet Cytogenet. 2000;116:153–7.

    Article  CAS  PubMed  Google Scholar 

  33. Zynger DL, Gupta A, Luan C, Chou PM, Yang GY, Yang XJ. Expression of glypican 3 in hepatoblastoma: an immunohistochemical study of 65 cases. Hum Pathol. 2008;39:224–30.

    Article  CAS  PubMed  Google Scholar 

  34. Chan ES, Pawel BR, Corao DA, Venneti S, Russo P, Santi M, et al. Immunohistochemical expression of glypican-3 in pediatric tumors: an analysis of 414 cases. Pediatr Dev Pathol. 2013;16:272–7.

    Article  PubMed  Google Scholar 

  35. Buetow PC, Buck JL, Pantongrag-Brown L, Marshall WH, Ros PR, Levine MS, et al. Undifferentiated (embryonal) sarcoma of the liver: pathologic basis of imaging findings in 28 cases. Radiology. 1997;203:779–83.

    Article  CAS  PubMed  Google Scholar 

  36. Yoon JY, Lee JM, Kim do Y, Choi GH, Park YN, Chung JW, et al. A case of embryonal sarcoma of the liver mimicking a hydatid cyst in an adult. Gut Liver. 2010;4:245–9.

    Article  PubMed Central  PubMed  Google Scholar 

  37. Stocker JT, Ishak KG. Undifferentiated (embryonal) sarcoma of the liver: report of 31 cases. Cancer. 1978;42:336–48.

    Article  CAS  PubMed  Google Scholar 

  38. Lack EE, Schloo BL, Azumi N, Travis WD, Grier HE, Kozakewich HP. Undifferentiated (embryonal) sarcoma of the liver. Clinical and pathologic study of 16 cases with emphasis on immunohistochemical features. Am J Surg Pathol. 1991;15:1–16.

    Article  CAS  PubMed  Google Scholar 

  39. Perez-Gomez RM, Soria-Cespedes D, de Leon-Bojorge B, Ortiz-Hidalgo C. Diffuse membranous immunoreactivity of CD56 and paranuclear dot-like staining pattern of cytokeratins AE1/3, CAM5.2, and OSCAR in undifferentiated (embryonal) sarcoma of the liver. Appl Immunohistochem Mol Morphol. 2010;18:195–8.

    Article  PubMed  Google Scholar 

  40. Kiani B, Ferrell LD, Qualman S, Frankel WL. Immunohistochemical analysis of embryonal sarcoma of the liver. Appl Immunohistochem Mol Morphol. 2006;14:193–7.

    Article  PubMed  Google Scholar 

  41. Zheng JM, Tao X, Xu AM, Chen XF, Wu MC, Zhang SH. Primary and recurrent embryonal sarcoma of the liver: clinicopathological and immunohistochemical analysis. Histopathology. 2007;51:195–203.

    Article  PubMed  Google Scholar 

  42. Lauwers GY, Grant LD, Donnelly WH, Meloni AM, Foss RM, Sanberg AA, et al. Hepatic undifferentiated (embryonal) sarcoma arising in a mesenchymal hamartoma. Am J Surg Pathol. 1997;21:1248–54.

    Article  CAS  PubMed  Google Scholar 

  43. O’Sullivan MJ, Swanson PE, Knoll J, Taboada EM, Dehner LP. Undifferentiated embryonal sarcoma with unusual features arising within mesenchymal hamartoma of the liver: report of a case and review of the literature. Pediatr Dev Pathol. 2001;4:482–9.

    Article  PubMed  Google Scholar 

  44. de Chadarevian JP, Pawel BR, Faerber EN, Weintraub WH. Undifferentiated (embryonal) sarcoma arising in conjunction with mesenchymal hamartoma of the liver. Mod Pathol. 1994;7:490–3.

    PubMed  Google Scholar 

  45. Bove KE, Blough RI, Soukup S. Third report of t(19q)(13.4) in mesenchymal hamartoma of liver with comments on link to embryonal sarcoma. Pediatr Dev Pathol. 1998;1:438–42.

    Article  CAS  PubMed  Google Scholar 

  46. Levy M, Trivedi A, Zhang J, Miles L, Mattis AN, Kim GE, et al. Expression of glypican-3 in undifferentiated embryonal sarcoma and mesenchymal hamartoma of the liver. Hum Pathol. 2012;43:695–701.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  47. Nicol K, Savell V, Moore J, Teot L, Spunt SL, Qualman S. Distinguishing undifferentiated embryonal sarcoma of the liver from biliary tract rhabdomyosarcoma: a Children’s Oncology Group study. Pediatr Dev Pathol. 2007;10:89–97.

    Article  PubMed  Google Scholar 

  48. Kebudi R, Gorgun O, Ayan I, Cosar R, Bilgic B. Rhabdomyosarcoma of the biliary tree. Pediatr Int. 2003;45:469–71.

    Article  PubMed  Google Scholar 

  49. Nemade B, Talapatra K, Shet T, Banavali S, Muckaden MA, Laskar S. Embryonal rhabdomyosarcoma of the biliary tree mimicking a choledochal cyst. J Cancer Res Ther. 2007;3:40–2.

    Article  PubMed  Google Scholar 

  50. Ishak KG, Goodman ZD, Stocker JT. Armed Forces Institute of Pathology (U.S.), Universities Associated for Research and Education in Pathology. Tumors of the liver and intrahepatic bile ducts. Washington, DC: Armed Forces Institute of Pathology; 2001.

    Google Scholar 

  51. Makhlouf HR, Abdul-Al HM, Wang G, Goodman ZD. Calcifying nested stromal-epithelial tumors of the liver: a clinicopathologic, immunohistochemical, and molecular genetic study of 9 cases with a long-term follow-up. Am J Surg Pathol. 2009;33:976–83.

    Article  PubMed  Google Scholar 

  52. Hill DA, Swanson PE, Anderson K, Covinsky MH, Finn LS, Ruchelli ED, et al. Desmoplastic nested spindle cell tumor of liver: report of four cases of a proposed new entity. Am J Surg Pathol. 2005;29:1–9.

    Article  PubMed  Google Scholar 

  53. Heywood G, Burgart LJ, Nagorney DM. Ossifying malignant mixed epithelial and stromal tumor of the liver: a case report of a previously undescribed tumor. Cancer. 2002;94:1018–22.

    Article  PubMed  Google Scholar 

  54. Heerema-McKenney A, Leuschner I, Smith N, Sennesh J, Finegold MJ. Nested stromal epithelial tumor of the liver: six cases of a distinctive pediatric neoplasm with frequent calcifications and association with Cushing syndrome. Am J Surg Pathol. 2005;29:10–20.

    Article  PubMed  Google Scholar 

  55. Geramizadeh B, Foroutan H, Foroutan A, Bordbar M. Nested stromal epithelial tumor of liver presenting with Cushing syndrome: a rare case report. Indian J Pathol Microbiol. 2012;55:253–5.

    Article  PubMed  Google Scholar 

  56. Brodsky SV, Sandoval C, Sharma N, Yusuf Y, Facciuto ME, Humphrey M, et al. Recurrent nested stromal epithelial tumor of the liver with extrahepatic metastasis: case report and review of literature. Pediatr Dev Pathol. 2008;11:469–73.

    Article  PubMed  Google Scholar 

  57. Hommann M, Kaemmerer D, Daffner W, Prasad V, Baum RP, Petrovitch A, et al. Nested stromal epithelial tumor of the liver—liver transplantation and follow-up. J Gastrointest Cancer. 2011;42:292–5.

    Article  PubMed  Google Scholar 

  58. Assmann G, Kappler R, Zeindl-Eberhart E, Schmid I, Haberle B, Graeb C, et al. beta-Catenin mutations in 2 nested stromal epithelial tumors of the liver—a neoplasia with defective mesenchymal-epithelial transition. Hum Pathol. 2012;43:1815–27.

    Article  CAS  PubMed  Google Scholar 

  59. Procopio F, Di Tommaso L, Armenia S, Quagliuolo V, Roncalli M, Torzilli G. Nested stromal-epithelial tumour of the liver: an unusual liver entity. World J Hepatol. 2014;6:155–9.

    Article  PubMed Central  PubMed  Google Scholar 

  60. Oviedo Ramirez MI, Bas Bernal A, Ortiz Ruiz E, Bermejo J, De Alava E, Hernandez T. Desmoplastic nested spindle cell tumor of the liver in an adult. Ann Diagn Pathol. 2010;14:44–9.

    Article  PubMed  Google Scholar 

  61. Cross SS, Variend S. Combined hepatoblastoma and yolk sac tumor of the liver. Cancer. 1992;69:1323–6.

    Article  CAS  PubMed  Google Scholar 

  62. Lisovsky M, Konstas AA, Misdraji J. Congenital extrahepatic portosystemic shunts (Abernethy malformation): a histopathologic evaluation. Am J Surg Pathol. 2011;35:1381–90.

    Article  PubMed  Google Scholar 

  63. Klein WM, Molmenti EP, Colombani PM, Grover DS, Schwarz KB, Boitnott J, et al. Primary liver carcinoma arising in people younger than 30 years. Am J Clin Pathol. 2005;124:512–8.

    Article  PubMed  Google Scholar 

  64. Deneau M, Adler DG, Schwartz JJ, Hutson W, Sorensen J, Book L, et al. Cholangiocarcinoma in a 17-year-old boy with primary sclerosing cholangitis and inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2011;52:617–20.

    Article  PubMed  Google Scholar 

  65. Tanaka S, Kubota M, Yagi M, Okuyama N, Ohtaki M, Yamazaki S, et al. An 11-year-old male patient demonstrating cholangiocarcinoma associated with congenital biliary dilatation. J Pediatr Surg. 2006;41:e15–9.

    Article  PubMed  Google Scholar 

  66. Scheimann AO, Strautnieks SS, Knisely AS, Byrne JA, Thompson RJ, Finegold MJ. Mutations in bile salt export pump (ABCB11) in two children with progressive familial intrahepatic cholestasis and cholangiocarcinoma. J Pediatr. 2007;150:556–9.

    Article  CAS  PubMed  Google Scholar 

  67. Blohm ME, Vesterling-Horner D, Calaminus G, Gobel U. Alpha 1-fetoprotein (AFP) reference values in infants up to 2 years of age. Pediatr Hematol Oncol. 1998;15:135–42.

    Article  CAS  PubMed  Google Scholar 

  68. Blair JI, Carachi R, Gupta R, Sim FG, McAllister EJ, Weston R. Plasma alpha fetoprotein reference ranges in infancy: effect of prematurity. Arch Dis Child. 1987;62:362–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  69. Bailey D, Colantonio D, Kyriakopoulou L, Cohen AH, Chan MK, Armbruster D, et al. Marked biological variance in endocrine and biochemical markers in childhood: establishment of pediatric reference intervals using healthy community children from the CALIPER cohort. Clin Chem. 2013;59:1393–405.

    Article  CAS  PubMed  Google Scholar 

  70. Soldin OP, Dahlin JR, Gresham EG, King J, Soldin SJ. IMMULITE 2000 age and sex-specific reference intervals for alpha fetoprotein, homocysteine, insulin, insulin-like growth factor-1, insulin-like growth factor binding protein-3, C-peptide, immunoglobulin E and intact parathyroid hormone. Clin Biochem. 2008;41:937–42.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  71. Bader D, Riskin A, Vafsi O, Tamir A, Peskin B, Israel N, et al. Alpha-fetoprotein in the early neonatal period—a large study and review of the literature. Clin Chim Acta. 2004;349:15–23.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Anatomic Pathology, Department of Laboratory Medicine and Pathology, Mayo Clinic, 200 First St. SW, Rochester, MN, 55905, USA

    Roger K. Moreira M.D.

Authors
  1. Roger K. Moreira M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roger K. Moreira M.D. .

Editor information

Editors and Affiliations

  1. Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA

    Taofic Mounajjed

  2. Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA

    Vishal S. Chandan

  3. Department of Laboratory Medicine and Pathology, Mayo Clinic College of Medicine, Rochester, Minnesota, USA

    Michael S. Torbenson

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Moreira, R.K. (2015). Malignant Pediatric Liver Tumors. In: Mounajjed, T., Chandan, V., Torbenson, M. (eds) Surgical Pathology of Liver Tumors. Springer, Cham. https://doi.org/10.1007/978-3-319-16089-4_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-16089-4_14

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-16088-7

  • Online ISBN: 978-3-319-16089-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation